chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LITTLE DROP IN THE  ANTIBODY LEVEL; This spontaneous report received from a consumer via a company representative concerned a 60 year old female. The patient's height, and weight were not reported. The patient's past medical history included: covid-19 (The patient contracted Covid in FEB-2020), and other pre-existing medical conditions included: The patient was in good health. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced little drop in the antibody level. Laboratory data (dates unspecified) included: Antibody test (NR: not provided) drop (little drop in the antibody level). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of little drop in the antibody level was not reported. This report was non-serious. This case, from the same reporter is linked to 20220558518.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case is assessed as non-serious
felt an allergy in his nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINITIS ALLERGIC (felt an allergy in his nose) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 12-Jan-2021. Concomitant products included ZINC for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced RHINITIS ALLERGIC (felt an allergy in his nose). At the time of the report, RHINITIS ALLERGIC (felt an allergy in his nose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, SARS-CoV-2 test positive: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Patient received the first dose of the Pfizer COVID vaccine on a Wednesday afternoon, and was monitored afterward. Nothing unusual was noted. Thursday patient had an unrelated doctor visit and septic arthritis in shoulder was assessed. Patient was baseline. Friday morning patient passed away unexpectedly.
I woke up the day after getting the vaccine noticing that my sinuses were a little stuffy. I was thinking it may be the unseasonable weather, so I didn't pay much attention to it. The next day when I got up my sinuses were not only stuffy, but my ears were also stuffy, itchy, running.  I made an appointment to go to the doctor. She felt that it may just be allergies, she gave me a prescription for Singulair. I also made an appointment with an ENT to ensure that I did not have anything blocking my ear canal. He did not see anything in my ear and gave me steroid ear drops. Both the Singulair and steroid ear drops have helped to remedy the my stuffiness.
pt recvd vax; pt devel fever w/ t 102 & emesis;pt dx w/ erythema multiforme; lab tests revealed low tot protein 4.9; albumin 2.4; serum iron 43 & bun 2.; csf protein was 85 & csf glucose was 31;
Information has been received from a registered pharmacist concerning a 34 year old male smoker patient, with penicillin allergy, diabetes, intractable gastric reflux, Touretts disorder, hematuria and headaches, who on 10-NOV-2010, while in the hospital recovering from "lapfundoplasty" surgery for intractable GERD, was vaccinated with a dose of PNEUMOVAX 23 (lot #, expire date and route not reported), 0.5 ml. Concomitant therapy included NEXIUM, GOLYTELY, nystatin, morphine, famotidine (MSD), TYLOX, LORTAB and doxycycline. On 10-NOV-2010 the patient was discharged from hospital and returned the next day (on 11-NOV-2010) with a 3 cm erythemic area at the injection site. The patient was sent home. On 12-NOV-2010 the patient returned to the hospital because the injection site reaction had grown to 6 to 7 cm and became indurated and on 12-NOV-2010 the patient was admitted to the hospital for observation. Injection site reaction had not yet been treated. At the time of the report, the patient had not recovered. Additional information has been requested. This is an amended report. Upon review of the file, the code medication error-inappropriate schedule of drug administered had been removed.
A wheal was not present after the first attempt. The second attempt was done by an expert in intradermal administration, a wheal was formed, and the attempt was successful.
This spontaneous report as received from certified medical assistant refers to a patient of unknown age and unknown gender. Drug reactions, allergies and pertinent medical history were unspecified. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, dose number, route, anatomical location, lot number and expiration date were not reported). Concomitant therapies were not reported. On approximately 23-JUN-2014 (reported as the last week) the patient went to the reporter's office and was diagnosed with a zoster-like rash. Treatment given for the zoster-like rash was unspecified. Laboratory diagnostic studies were unspecified. The outcome of the zoster-like rash was unknown. The relationship between the zoster-like rash and ZOSTAVAX was not reported. Additional information has been requested. Correspondence containing a request for additional information is scheduled.
Patient reported adverse event 7/28/11. Vaccine adm 7/14/11. Reported small blisters to injection site currently resolving dry flaky area tender to touch. Advised to keep covered.
Moderate Flu-like symptoms for ~24 hours: 100.6F fever Extreme shaking/shivering Vomiting Aching body & head
Information has been received from a physician concerning a 19 year old female with a history of migraines who on 18-JAN-2008 was vaccinated with her third dose of Gardasil. Concomitant therapy included MANTOUX SKIN TEST. Approximately 15 minutes after receiving the vaccination on 18-JAN-2008 the patient fell down and had a loss of consciousness for a few seconds. The patient was taken to the emergency room where her vital signs were checked and everything was normal. She was discharged that day with a "clean bill of health." The patient did not have an adverse reaction to the first or second dose of the vaccine. Subsequently, the patient recovered on 21-JAN-2008 from falling down and loss of consciousness for a few seconds. Additional information has been requested.  Follow-up received 04/16/2008. Concomitant therapy included tuberculin purified protein derivative (MANTOUX SKIN TEST) (LOT # C2670AA) and topical acne medications. Approximately 15 minutes after receiving the vaccination on 18-JAN-2008 the patient fell down and struck her head, completely breaking through the dry wall and had a loss of consciousness for a few seconds. Patient was alert within 10-15 seconds. Her vital signs immediately following the episode were within normal limits. The patient was transferred to the emergency room with a neck collar and back board where she was evaluated and diagnosed with a closed head injury adn vaso-vagal reaction. She was discharged that day with a "clean bill of health." The patient did not have an adverse reaction to the first or second dose of the vaccine. Subsequently, the patient recovered on 21-JAN-2008 from falling down and loss of consciousness for a few seconds. Additional information has been requested.
We both of us very fatigue; Little nauseated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 06Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1), for Covid-19 Immunization; Bnt162b2 (Dose Number: 2), for Covid-19 Immunization. The following information was reported: FATIGUE (non-serious) with onset 06Oct2021, outcome "not recovered", described as "We both of us very fatigue"; NAUSEA (non-serious) with onset 06Oct2021, outcome "recovered" (Oct2021), described as "Little nauseated".  Follow-up (25Oct2021): This is a follow up spontaneous report from a contactable consumer. This consumer reported in response to Non-HCP letter sent to consumer via telephonic follow-up activity which included that: Any additional information: Phone Out 11:26 AM EST, 1st attempt by phone to non-HCP to obtain mailing information. Phone answered by the consumer who provided his mailing address. Consumer questionnaire forwarded to reporting mailbox Consumer's mailing address is: withheld  Follow-up (08Nov2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101376484 same reporter/product, different patient / event.
a 3rd dose booster  was given to a child 14 years old, prior to company protocol being updated. The CDC had just approved 12-15 old for booster. Patient came in and the 3rd shot was given with no complications.
72 year old vaccinated female was admitted for SVT and Covid-19 pneumonia. She was treated with Remdesivir. She converted back to NSR spontaneously and did not need intervention. Cardiology signed off. She will be transferred today for rehab.
11/2/22 Received vaccination in left deltoid area. Nothing seemed unusual, no pain during administration 11/3/22 Woke up with some typical arm soreness but also a ?crick? in my left neck. Neck was pretty sore by evening and I laid on heating pad. 11/4/22-11/6/22 Pain progressed to nerve pain, felt like impingement in my left upper back behind my shoulder blade and my left neck was so painful I couldn?t turn my head. My left arm was tingling down to my fingers and palm of my hand, especially my 4th and 5th fingers. The tingling spread to my left face and jaw over 11/5 and 11/6. It was gradual, not sudden. Took some ibuprofen and continued to use heat. Tried massaging it which didn?t seem to help. 11/7/22- Called primary MD Dr. who wasn?t in that day and went to see Dr.. He prescribed a 5 day course of steroids in the mornings and muscle relaxer for bedtime. I am taking the steroids but not the muscle relaxers because I don?t like to take medicine at all. I?m taking ibuprofen and using the heating pad at night instead. 11/9/22- It is day 3 of steroids and while the pain is significantly better, the tingling is still present in my hand and face. I?m scared it isn?t going to go away.
Patient developed 3 blisters around injection site the day after injection received. Blisters "pea" size. 2 blisters approx. 1/4" from injection site and 1 blister approx. 2" from injection site. 5 days after injection blisters improving and looking like "big pimples".
Developed flu-like symptoms and significant swelling/erythema at site of injection with both shots. Felt perfect prior to injections. I did think the F/U like Sx were significant and the site of injection erythema/edema was also significant. It was an identical reaction with both injections. I feel GSK should tell people about this reaction. It was self-limited but I did not feel well for several days with both injections.
My joints ache all the time.  My lungs hurt all the time at the top when I breath , I get short of breath easily and get fatigued easily.  Before the shot I didn?t have any of these issues.
11/15/2022 late in the evening I developed a runny nose. 11/16 tickle in the throat, and increased volume of nasal drainage. 11/17 Tele-visit with doctor as at home COVID-19 test was positive. Doctor recommended treating symptomatically and resting. Symptoms lasted until at least 11/30 with head congestion. Symptoms tapered off into nothing.
Patient was here for 2nd HPV vaccine and was inadvertently given a 3rd Hep A vaccine instead.   Patient made aware of error.   Patient denied any adverse reaction.
Narrative: Patient presented to COVID triage tent requesting to be screened for COVID 19. Patient complained of headache, body aches, nasal drainage, congestion, dry cough and loss of taste and smell. Symptoms started approximately 4 days prior to presentation for testing. Patient reportes receiving the Moderna vaccine x 2 at non Facility 1/5/21 and 2/9/21.
Left arm swelling, redness, warmth, itching/ pain consistent with cellulitis/ erysipelas
Patient presented to ED on 9-14-2020 after reportedly 8 days of symptoms including fatigue , fevers, loss of speech. CT and MRI of brain showed ADEM (acute disseminated encephalomyelitis). Patient was admitted and discharged on 9-21-2020
Patient received second Pfizer vaccine dose.  Patient quickly developed an increased heart rate (up to 170s) and increased blood pressure to (160s/90s). Patient was transferred to the Emergency Department for further evaluation.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 75-year-old male patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included paraplegia (Patient is a paraplegic and has neurological issues). On 20th August 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In August 2018, several hours after receiving SHINGRIX, the patient experienced leg cramps, headache, neck pain and leg discomfort. On 20th August 2018, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm, leg cramps, headache, neck pain and leg discomfort were recovered/resolved. It was unknown if the reporter considered the pain in arm, leg cramps, headache, neck pain and leg discomfort to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's wife. In the morning around 10:30 AM, the patient received SHINGRIX on right arm. Six hours after receiving SHINGRIX, the patient experienced arm pain and moved into neck and head pain with a bad headache. Then (several hours after vaccination) the patient experienced spasms in both legs and he could not straighten out his legs which lasted 8 hours. All of his side effects had since resolved. This is 1 of the 4 linked cases reported by the same reporter.
Thyroid cancer,  lupus.  I do not have any family history of either problems?mother side or father side.  I am 58 ?Dec. 2022?at the time diagnosed lupus.
bleeding in the left eye, described by the reporter as capillaries bursting; swelling of both eyes; leaving red in the eye; left cheek bone pain; Hives about the face; This case was reported by a consumer via call center representative and described the occurrence of eye hemorrhage in a 81-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th May 2021, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced eye hemorrhage (serious criteria GSK medically significant), eye swelling, eye red, bone pain and hives. On an unknown date, the outcome of the eye hemorrhage, eye swelling, bone pain and hives were not recovered/not resolved and the outcome of the eye red was unknown.   It was unknown if the reporter considered the eye hemorrhage, eye swelling, eye red, bone pain and hives to be related to Shingrix.  Additional detail were reported as follows: The case was reported by the patient's daughter. The patient received the 1st dose of Shingrix 15 days prior to the report in a pharmacy. After several unspecified hours, the patient began to experience hives about the face. The patient experienced bleeding in the left eye, described by the reporter as capillaries bursting and leaving red in the eye. The patient also experienced left cheek bone pain and swelling of both eyes. It was not known how soon other events began relative to receiving the dose. The reporter consented to follow up.
She received intradermal Influenza vaccine in right arm at hospital "Flu Clinic" on 10/12/12. Ever since, she has experienced aching in upper right arm when raises elbow to shoulder height or higher. No medical treatment sought.
Mother of child states child had a rash on her neck, chest, back, arms and legs when she was picked up from daycare yesterday around 4 pm. Child was taken to family Dr on 9/13/18. Dr seen child with no further treatment. As of 9/13/18 rash is unchanged.
Right arm pain instantly after injection given very high on my right deltoid. Pain continued limiting the use of my right arm. Pain to shoulder/upper arm with lifting, getting dressed, raising arm up along with numbness extending down my right arm.
This spontaneous report as received from a registered nurse refers to a 14 year old patient. On 06-FEB-2013, the patient was vaccinated with a dose of PROQUAD (merck) (Lot # not reported). No adverse event was reported. The nurse also stated that the patient had received the first dose of M-M-R II on 16-OCT-2002 and the first dose of VARIVAX (Merck) on 12-MAY-1999. Additional information is not expected.
Sore all weekend at injection location. Chills very early day after injection. Headache.
Information has been received from a licensed practical nurse (LPN) concerning a 55 yr old male with diabetes and no known allergies who on approx 07Nov05 was vaccinated IM with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot651328/1046P). Concomitant therapy included diabetic medication (therapy unspecified). Subsequently, the pt developed red, hot, painful and grapefruit size areas at the injection site. Medical attention was sought. The pt was treated with compresses. The pt was reported as not recovered. There was no product quality complaint involved. Additional information has been requested.
lightheaded, dizzy, room spinning 110/64 P 64 improving with water and juice
Anaphylactic reaction; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A female patient of an unspecified age received bnt162b2 (COMIRNATY Formulation: solution for injection Batch/Lot number was not reported) via an unspecified route of administration on 27Jan2021 as dose 2, single for COVID-19 immunisation. Medical history included connective tissue disorder (Genetic connective tissue) and` congenital anomaly (Birth defects) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (COMIRNATY Formulation: solution for injection Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a dose 1, single for COVID-19 immunisation. After 2nd dose of vaccine the patient experienced anaphylactic reaction, felt like something was stuck in her throat, tongue became swollen and red on an unspecified date in 2021 which later ended up to visit emergency room. The patient wanted to know if ok to get a 3rd dose of pfizer covid vaccine given her anaphylactic experience after the 2nd. Reporter clarified that although she has hx of genetic connective tissue and birth defects, she did not consider herself immunosuppressed. Reporter clarified that it is the booster and not the 3rd dose that she is wanting to get. Patient said, she started taking ramipril 1.5 weeks ago and developed arm pain; described as muscle and joint pain from shoulders to her fingers. asking will it go away and if so then when? Also, as per agent, reporter had 2nd dose of pfizer covid vaccine on Jan 27th and experienced an anaphalytic reaction. She felt like something was stuck in her throat and tongue became swollen and red. She was given epipen and benadryl and sent to Emergency Dept and treated with additional medications and then released 9 hrs later. She was asking for recommendations for other types of covid 19 vaccines should/could she get if she should not get pfizer covid vaccine. The outcome of events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Upon awakening the following morning, I saw a huge red welt on my forehead above the right eye. I also felt flushed, muscle soreness, and overall weakness/tiredness. There is redness/swelling at the injection site.
NauseaVomiting localized pain at injection site for 3 days Narrative:
Started with mild headache around the evening, that got worse (similar to a migraine headache) starting around 9PM. around that same time started feeling body aches. Woke up the next morning feeling the same but also very feverish going between chills and sweating. Couldn?t really get out of bed (muscle aches and fatigue) and slept all day. Started to feel better around 4pm, but started to feel worse again around 9pm, very bad chills all night until about 4am where I woke up sweating unable to cool down, headache mild.
Pediatric vaccine was diluted with 0.13 ml instead of 1.3 ml so the patient got a more concentrated dosage than recommended. Patient presented pain at administration site and lymphadenopathy that resolved after 72 hours
congestion in his ears, nose and throat. He went to the ER; congestion in his ears, nose and throat. He went to the ER; congestion in his ears, nose and throat. He went to the ER; This is a Spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (reported as 'Saturday') at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the Covid vaccine on Saturday and last night (25Jan2021) he started to get congestion in his ears, nose and throat. He went to the ER this morning and they told him it could be side effects from getting the Covid vaccine. He needed to know for work how long the side effects could last. The outcome of the events was unknown  Information on the Lot/Batch number has been requested.
Patient complained of 2 of the 3 injection sites as being red, painful. Hurts to move arm in the shoulder area. No fever. Provider noted that it was not an adverse reaction to the vaccines but diagnosed as a local infection of skin and subcutaneous tissue. Patient was prescribed cephalexin 250 MG, encouraged fluids and rest. Acetaminophen or ibuprofen as needed for fever or pain. Call office if not improving or worsens.
This spontaneous report was received from a healthcare worker regarding unspecified number of patients of an unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, unspecified number of patients were vaccinated with improperly stored PEDVAXHIB (Lot #, dose and route were not reported). No symptoms were reported. This is one of the several reports from the same reporter. Additional information has been requested.
This is on my right hand and I can see inflammation and splotches. It gets dry over those cracking areas. I was using this prescription triamcinolone acetonide. I've been using a lot of hand cream in addition to this prescription. Using Vaseline hand cream as well. Unsure if this has anything to do with the vaccine or not. Had one appointment with Dermatology and that's where I got my prescription. I'm looking to see if there's a record like this of people having skin issues or anything related.